Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
2hon MSN
Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...
PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of ...
Everyday Health on MSN
MASH: Is semaglutide right for you?
Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH treatment plan.
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
I am bullish on healthcare stocks, especially pharmaceuticals, due to conservative valuations. Check out the healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results